French diagnostics association pushes for recognition:
This article was originally published in Clinica
SFRL, the French diagnostics industry association, wants the importance of lab testing to be recognised as a basis for better decisions in healthcare. The French association has been battling against severe cuts in healthcare, is to launch a national campaign on the role of IVD in healthcare. Claude Buffard remains president of the association. Michel Doucet (bioMerieux) becomes vice-president, Jacqueline Bremond (Abbott) general secretary, and Alain Flechel (Roche) treasurer.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.